Liposomes loaded with antibiotics eliminate intracellular bacteria in a colorectal cancer model, unleashing antitumor T cell immunity.
References
Wang, M. L. et al. Nat. Biotechnol. https://doi.org/10.1038/s41587-023-01957-8 (2023).
Kuai, R., Ochyl, L. J., Bahjat, K. S., Schwendeman, A. & Moon, J. J. Nat. Mater. 16, 489–496 (2017).
Zamora, A. E., Crawford, J. C. & Thomas, P. G. J. Immunol. 200, 392–399 (2018).
Galeano Niño, J. L. et al. Nature 611, 810–817 (2022).
Kalaora, S. et al. Nature 592, 138–143 (2021).
Naghavian, R. et al. Nature 617, 807–817 (2023).
Nejman, D. et al. Science 368, 973–980 (2020).
Seynhaeve, A. L. B., Amin, M., Haemmerich, D., van Rhoon, G. C. & Ten Hagen, T. L. M. Adv. Drug Deliv. Rev. 163-164, 125–144 (2020).
Riquelme, E. et al. Cell 178, 795–806.e12 (2019).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
J.J.M. declares financial interests for board membership, as a paid consultant, for research funding, and/or as an equity holder in EVOQ Therapeutics and Saros Therapeutics.
Rights and permissions
About this article
Cite this article
Han, K., Cho, Y.S. & Moon, J.J. Antibiotic nanoparticles boost antitumor immunity. Nat Biotechnol (2023). https://doi.org/10.1038/s41587-023-02046-6
Published:
DOI: https://doi.org/10.1038/s41587-023-02046-6
- Springer Nature America, Inc.